ArticleBurns & trauma2026
SFL-3D-cultured adipose mesenchymal cell-derived extracellular vesicles promote diabetic wound healing by alleviating microvascular endothelial senescence
Article in Burns & trauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extracellular vesicles in wound healing and scar formation: molecular regulation of macrophages, fibroblasts, and their crosstalk.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic foot ulcers (DFUs) are severe complications of diabetes, and treatment options for DFUs are limited. Current research on impaired angiogenesis in DFUs predominantly relies on generic endothelial cells, which inadequately reflect the pathophysiological microenvironment of the diabetic microvasculature. In contrast, this study focused specifically on human dermal microvascular endothelial cell (HDMEC) senescence as a central mechanism in DFU progression. We used a self-feeder layer 3D (SFL-3D) culture system to reprogram adipose-derived mesenchymal stem cells (ADSCs) to prepare functionally enhanced three-dimensional adipose stem cells (tdASCs) and their extracellular vesicles (tdASC-EVs) to mitigate HDMEC senescence and improve diabetic healing. Methods: EVs were isolated from SFL-3D-induced tdASCs and characterized. Results: tdASC-EVs significantly attenuated high-glucose-induced HDMEC senescence, oxidative stress, and mitochondrial dysfunction while increasing tube formation. Mechanistically, tdASC-EVs activated PI3K/AKT/mTOR signaling, increased 4EBP1 phosphorylation, and promoted eIF4E-eIF4G assembly. In diabetic mice, tdASC-EVs accelerated wound closure and increased microvascular density, which correlated with reduced p16 expression and increased CD31 and p-4EBP1 expression. In the Bama miniature pig diabetic large animal model, tdASC-EVs exhibited markedly superior therapeutic effects compared with those induced by conventional ADSC-EVs, as evidenced by significantly faster wound closure, greater neovascularization density, narrower scar width, and more orderly collagen deposition. Conclusions: tdASC-EVs ameliorated diabetic wound healing by targeting HDMEC senescence through PI3K/AKT/mTOR/4EBP1-mediated cap-dependent translational activation. The preclinical large animal data further confirmed the superior efficacy of tdASC-EVs over ADSC-EVs, highlighting the therapeutic potential of SFL-3D-modified EVs for DFU treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.